McHale Duncan's Form 4 filing
Evelo Biosciences, Inc. (EVLO) · filed May 31, 2022
- Accession no.
- 0001694665-22-000087
- Filed
- May 31, 2022
- Trade date
- May 27, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $50.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McHale DuncanCIK 0001738896 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Common Stock | PPurchaseAcquired | +34,246 | $1.46 | +$49,999.16 | 34,246 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.